Literature DB >> 1356428

Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations.

M Nakata1, A Kawasaki, M Azuma, K Tsuji, H Matsuda, Y Shinkai, H Yagita, K Okumura.   

Abstract

To verify the physiological role of the pore-forming protein perforin in vivo, its expression in subpopulations of human peripheral blood lymphocytes was examined by immunocytochemical staining and their cytolytic potentials compared. In addition to NK cells and gamma delta T cells, which uniformly expressed abundant perforin in their cytoplasmic granules, only a small subpopulation of CD8+ alpha beta T cells contained perforin, namely the CD11b+ subset. However, in vitro activation with an anti-CD3 antibody and IL-2 induced perforin expression in approximately 50% of the CD8+CD11b- T cells and also in a small subset of CD4+ T cells. A distribution of perforin in CD8+ and CD4+ T cells, similar to in vitro activated T cells, was observed in fresh peripheral blood lymphocytes from infectious mononucleosis patients. In all instances, the expression of perforin correlated with the cytolytic potential of these subpopulations. The results strongly suggest that perforin plays a role in the manifestation of cytotoxic activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356428     DOI: 10.1093/intimm/4.9.1049

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  21 in total

1.  Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

Authors:  S A Ghanekar; L E Nomura; M A Suni; L J Picker; H T Maecker; V C Maino
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Change in perforin-positive peripheral blood lymphocyte (PBL) subpopulations following exercise.

Authors:  R Staats; S Balkow; S Sorichter; H Northoff; H Matthys; W Luttmann; A Berg; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

3.  Quantitative fluorescence measures for determination of intracellular perforin content.

Authors:  Kevin J Maher; Nancy G Klimas; Barry Hurwitz; Richard Schiff; Mary Ann Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 4.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

5.  Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

Authors:  S Hanabuchi; M Koyanagi; A Kawasaki; N Shinohara; A Matsuzawa; Y Nishimura; Y Kobayashi; S Yonehara; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.

Authors:  Naoko Asano; Ritsuro Suzuki; Koichi Ohshima; Yoshitoyo Kagami; Fumihiro Ishida; Tadashi Yoshino; Hiroshi Ogawa; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

7.  Progressive decrease of CD8high+ CD28+ CD57- cells with ageing.

Authors:  J Merino; M A Martínez-González; M Rubio; S Inogés; A Sánchez-Ibarrola; M L Subirá
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

8.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.

Authors:  J Strehlau; M Pavlakis; M Lipman; M Shapiro; L Vasconcellos; W Harmon; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

9.  BLT-esterase in infectious mononucleosis.

Authors:  L Wagner; M Wiesholzer; C P Worman; G Lang; W Base
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 10.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.